Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. Trinity Biotech plc TRIB is likely to earn $1.16 per share in the next year ending December, 2015. Trinity Biotech's trailing-twelve-month operating margin is 18.98%. Meridian Bioscience VIVO may earn $1.07 per share in the next year ending September, 2015. Meridian Bioscience's PEG ratio is 2.19. SurModics SRDX is projected to earn $1.01 per share for the next year ending September, 2015. SurModics' trailing-twelve-month revenue is $56.16 million. Neogen NEOG is expected to earn $0.94 per share over the next year ending May, 2015. Neogen's trailing-twelve-month ROE is 10.59%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasDiagnostic Substances IndustryEPS EstimatesSmall capssmall-cap
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!